| galantamine hydrobromide / Generic mfg. |
2008-006278-13: Motor function optimization in advanced Parkinson’s disease patients, combined with galantamine to prevent visual hallucinations. |
|
|
| Ongoing | 4 | 10 | Europe | Reminyl Retard, Sinemet 125 mg, Reminyl Retard, Sinemet 125 mg | UMCG | patients with advanced (>5 years) Parkinson\'s disease and visual hallucinations. | | | | |
2011-006011-62: The ACER-study - examining the effects of galantamine on gait. De ACER-studie - onderzoek naar de effecten van galantamine op het looppatroon. |
|
|
| Ongoing | 4 | 60 | Europe | galantamine, Reminyl Tablets 4mg, Reminyl Tablets 8mg, Reminyl Tablets 12mg, Reminyl Tablets 4mg, Reminyl Tablets 8mg, Reminyl Tablets 12mg | Slotervaart Hospital, Stichting Klinisch Wetenschappelijk Onderzoek Slotervaartziekenhuis (SKWOSZ) | Dementia of the Alzheimer type Dementie van het type Alzheimer | | | | |
2005-003245-14: Neuronale Korrelate von dysfunktionellen Aufmerksamkeitskomponenten bei Patienten mit Schizophrenie: cholinerge Rezeptorsysteme und pharmakologische Therapie |
|
|
| Ongoing | 4 | 15 | Europe | Reminyl, Galantamin, | Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Aachen | Patienten mit DSM-IVTR diagnostizierter Schizophrenie | | | | |
2017-000569-61: Comparison of therapeutic strategies with Cholinesterase Inhibitors: stop or still (SOS) trial |
|
|
| Not yet recruiting | 4 | 1205 | Europe | Donepezil, Galantamine, Rivastigmine, Donepezil, N06DA04, N06DA03, Coated tablet, Prolonged-release capsule, Capsule, ARICEPT, REMINYL, RIVASTIGMINE | CHU de Bordeaux, DGOS PHRC N 2016 | Alzheimer disease Maladie d'Alzheimer, Diagnosis of probable or possible AD, defined according to the NINCDS-ARDRA criteria cMild to moderate stage, defined by a MMSE score above 15 at the time of pré-inclusion Nouveau cas de Maladie d'AlzheimerDiagnostic de MA probable ou possible définie selon les critères NINCDS-ARDRA, Diseases [C] - Nervous System Diseases [C10] | | | | |
NCT03454646: Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL) |
|
|
| Not yet recruiting | 4 | 1205 | Europe | cholinesterase inhibitors (CI) (donepezil, galantamine or rivastigmine) | University Hospital, Bordeaux | Alzheimer Disease, Cholinesterase Inhibitors | 04/27 | 09/27 | | |
